Stocktoria
CONMED Corp CNMD
NYSE · XNYS · stock · Electromedical & Electrotherapeutic Apparatus · website · IPO 1987-07-23
CONMED Corp statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 54.6% | 56.1% | 54.3% | 54.6% | 56.2% |
| Operating margin | 7.5% | 15.3% | 9.7% | 6.7% | 10.9% |
| Net margin | 3.4% | 10.1% | 5.2% | -7.7% | 6.2% |
| FCF margin | 11.0% | 11.8% | 8.5% | 1.1% | 9.6% |
| Return on assets | 2.0% | 5.7% | 2.8% | -3.5% | 3.5% |
| Return on equity | 4.6% | 13.8% | 7.7% | -10.8% | 8.0% |
| Current ratio | 2.14 | 2.30 | 1.98 | 1.96 | 2.34 |
| Revenue growth | 5.2% | 5.0% | 19.1% | 3.4% | 17.2% |
Source: SEC EDGAR filings · CIK 0000816956 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.